Abstract
Methods A database of prevailing drug procurement prices was created from actual purchase orders submitted in 2013 by government procuring entities in the Philippines. The database includes information on the unit cost, volumes of procurement, source/supplier/manufacturer, brand, mode of procurement and location of the hospital for each formulation and strength of all drugs in the National Formulary. Multivariate regression analyses were performed for commonly sourced essential drugs exploring possible determinants of drug costs, which include quantities procured and hospital bed capacity. Further cost comparisons were made for other potential determinants such as mode of procurement, supplier/manufacturer and distance of distribution.
Highlights
To develop a method of setting a Drug Price Reference Index (DPRI) in the Philippines to ensure good value for money in the procurement and reimbursement of essential medicines
A database of prevailing drug procurement prices was created from actual purchase orders submitted in 2013 by government procuring entities in the Philippines
Conslusion Based on the observed wide variations in drug procurement prices in the Philippines, setting the DPRI at the median value for most drugs was found to be an appropriate method to set ceiling prices for public sector procurement
Summary
Developing a Drug Price Reference Index in the Philippines Manuel A Haasis*, Anna M Guerrero, Marinette J Ladioray From 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis Vienna, Austria. Objectives To develop a method of setting a Drug Price Reference Index (DPRI) in the Philippines to ensure good value for money in the procurement and reimbursement of essential medicines.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
